Free Trial

Nepsis Inc. Trims Holdings in National Health Investors, Inc. (NYSE:NHI)

National Health Investors logo with Finance background

Nepsis Inc. reduced its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 43.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 60,776 shares of the real estate investment trust's stock after selling 46,945 shares during the quarter. National Health Investors comprises about 1.1% of Nepsis Inc.'s holdings, making the stock its 24th largest position. Nepsis Inc. owned approximately 0.13% of National Health Investors worth $4,489,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the company. SG Americas Securities LLC purchased a new stake in shares of National Health Investors in the first quarter valued at about $808,000. Farther Finance Advisors LLC lifted its position in National Health Investors by 5,000.0% in the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock valued at $68,000 after purchasing an additional 900 shares during the period. NBC Securities Inc. purchased a new stake in National Health Investors in the 1st quarter valued at approximately $1,186,000. GAMMA Investing LLC increased its position in National Health Investors by 8,469.9% during the 1st quarter. GAMMA Investing LLC now owns 13,369 shares of the real estate investment trust's stock worth $987,000 after purchasing an additional 13,213 shares during the period. Finally, California State Teachers Retirement System raised its stake in shares of National Health Investors by 4.7% during the 4th quarter. California State Teachers Retirement System now owns 42,896 shares of the real estate investment trust's stock worth $2,973,000 after buying an additional 1,934 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.

Analyst Ratings Changes

NHI has been the topic of a number of recent analyst reports. Truist Financial upped their price objective on National Health Investors from $76.00 to $77.00 and gave the stock a "hold" rating in a report on Monday. Wedbush reaffirmed an "outperform" rating and set a $88.00 price target on shares of National Health Investors in a research note on Monday, March 17th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $85.75.

Check Out Our Latest Stock Analysis on National Health Investors

National Health Investors Price Performance

NYSE NHI traded down $0.72 during mid-day trading on Friday, hitting $70.89. The stock had a trading volume of 231,833 shares, compared to its average volume of 239,992. The company has a 50 day simple moving average of $73.74 and a 200 day simple moving average of $71.97. The company has a market cap of $3.31 billion, a price-to-earnings ratio of 24.36, a P/E/G ratio of 4.42 and a beta of 0.75. National Health Investors, Inc. has a 52-week low of $65.13 and a 52-week high of $86.13. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $68.87 million during the quarter, compared to analysts' expectations of $85.13 million. During the same quarter last year, the business posted $1.10 earnings per share. The business's revenue for the quarter was up 9.6% on a year-over-year basis. Equities analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 5.08%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's dividend payout ratio (DPR) is presently 114.29%.

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Stories

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines